A new study shows that treatment with a lifestyle modification program of diet, exercise and behavioral therapy when used in combination with the weight loss medication sibutramine (Meridia�) resulted in significantly greater weight loss among obese adults than treatment with …

A new study reveals an attractive new target for therapies aimed at the treatment of obesity and related metabolic disorders, researchers report in the March Cell Metabolism. A novel compound, when delivered to rats on a high-fat diet, acted on …

The active chemical substance in Acomplia, rimonabant, is a cannabinoid receptor antagonist (CB1). Being chemical, it usually acts within a short time after intake and stays for a limited duration. Hence, a daily supply of the drug is needed for …

The weight loss medication sibutramine, when combined with behavior therapy, allowed hundreds of very obese adolescents to lose an average of 14 pounds over a year, according to a multicenter study in the July 18 Annals of Internal Medicine. Adolescents …

Meridia (sibutramine), combined with behavioural therapy, has been shown to be effective in helping obese teenagers lose weight, according to a study carried out by Dr. R Berkowitz and team at Children Hospital of Philadelphia. The researchers found the treatment …